RANZCR Annual Report 2022–2023

2023 ANNUAL REPORT

Achieving Our Strategic Goals

Summary of Activities and Progress

July 2022–June 2023

T H E CO LLEG E

The Royal Australian and New Zealand College of Radiologists (RANZCR)

The Values That Drive What We Do

Integrity

stakeholders through our honesty, transparency, and authenticity

Accountability

We take responsibility for all our actions, behaviours, performance, commitments, and decisions.

Inclusivity

We foster an inclusive workplace and clinical environments for people in Australia and New Zealand.

Innovation

We constantly strive to reimagine excellence in everything we do.

Our Purpose

To enable the safe and appropriate use of clinical radiology and radiation oncology to optimise health outcomes for our patients and society.

Board of Directors

Clinical A/Prof Sanjay Jeganathan President

Dr Peter O’Brien Elected Fellow

Dr Rajiv Rattan Dean, Faculty of Clinical Radiology

Prof John Slavotinek Elected Fellow

Dr Gerard Adams Dean, Faculty of Radiation Oncology

Dr Christian Wriedt Elected Fellow, Treasurer

Dr Gabriel Lau Chair, New Zealand Branch

Ms Yvonne Warner Non-Fellow

A MESSAGE FROM THE PRESIDENT

Clin A/Prof Sanjay Jeganathan

of examinations and training. But, unlike some colleges, we acted quickly in our budget planning to address the warning signs. The introduction of a joining fee for trainees and increases in other fees were a difficult decision for the Board and unpopular in some quarters, but the outcome has justified early intervention. Without these measures, the College budget would have deteriorated sharply, and we would be in the same situation as some of our sister colleges, with a negative balance sheet. Instead, aided by investment revaluations and lower outlays on travel, we achieved a healthy surplus for fiscal 2023 and an improved outlook for 2024. This means we have been able to maintain member services and plan for new services in the coming year.

The pandemic has not been the only threat to the sustainability of the medical colleges in recent times. In the background we and others are coping with rising compliance costs for Australian Medical Council (AMC) accreditations and louder demands from the National Health Practitioner Ombudsman, who in 2023 was granted a role to investigate complaints against the specialist colleges in respect of approved programs of study.

standards for interventional radiology (IR) and interventional neuroradiology (INR) in Australia and New Zealand and made application to the AMC for formal recognition of IR and INR as specialities. These standards establish nationally consistent, minimum performance levels that will help safeguard patients and reduce variability in the delivery of IR and INR services.

On the AI front we advanced well ahead of other medical organisations with the release of draft standards of practice for artificial intelligence in radiation oncology, following on from our position statement on AI in medicine, issued in 2022. The College is currently participating in a NHMRC project examining the ethical and social implications of AI in diagnosis and health screening. We also led the discussion at a European radiology conference in Vienna on building international collaboration on AI implementation. AI has critically important significance for our specialities, so it is imperative we continue to play a leading role in the development of appropriate regulation of the medical uses of intelligent machines.

The 2022–23 year was the start of a time we casually refer to as ‘post-pandemic’ or a ‘new normal’, an acknowledgement that the healthcare system has passed through a crisis and now entered a world which looks somewhat more like it did before COVID-19, but frankly is not. As with wars and volcanic eruptions, a deadly upheaval has created a fertile environment for growth and progress.

Part of the year was marked by activities directly related to the pandemic, including an external review of the College’s risk framework, reconnection with global networks shuttered by COVID and the revival of bilateral relationships in our specialities. Important meetings were held once again with radiological colleagues in Europe, US and Canada, and we worked to develop closer ties with the Japan Radiological Society, Korean Society of Radiology and the Asian Oceanian Society of Radiology. International dialogue is vital to technological progress and quality assurance in our profession, and it was a relief to me that we were able to resume these interactions. We also sought to lift our profile in New Zealand through high-level meetings with government and opposition representatives.

COVID had a sudden impact on the financial viability of the medical colleges. Our organisation, along with many others, faced unprecedented cost pressures, especially in relation to the management

Advocacy to government and other decision-makers remained a key focus over the year. To help members better understand this work, we issued the first of a series of special reports on advocacy activities. The Policy and Advocacy in Action report notes that College representatives and staff held 46 meetings with government agencies, including seven meetings with politicians, and prepared 11 submissions in the first six months of 2023.

Among the submissions was our preBudget call for full deregulation of MRI licensing, reinstatement of Radiation Oncology Health Program Grant funding for brachytherapy, access via GP referral to uterine fibroid embolisation and MBS funding for marker clips in breast cancer diagnosis and treatment. The last of these calls was immediately successful, with funding for the marker clips to commence in early 2024, while our representations on the MRI licence issue were well received and supported by key government figures. We launched a regional and rural training pathway (RRTP) pilot, which offers an initial five places with a full scholarship for RRTP trainees at accredited sites. This is our first step towards a training pathway we hope will boost the long-term clinical radiology and radiation oncology workforce in regional and rural Australia. In another first, the College released the first comprehensive version of the

We also made progress with internal reforms that seek to improve the College’s representation of all of its membership and ensure the effectiveness of its governing bodies. It has been my deeply held conviction throughout my presidency that we need to increase the number of women in our profession, in leadership roles and foster a more inclusive culture within the organisation. To that end, I am particularly pleased that during the year the Board agreed to establish a high-level taskforce to make recommendations on issues related to diversity, inclusion and equity in the College. The new taskforce is chaired by Prof Liz Kenny AO. Further, we have taken steps during 2023 to improve the Board’s processes and discharge of its corporate responsibilities. A new governance committee will oversee the induction and development of directors and review the Board’s competencies and performance, including its continuing ability to meet diversity obligations and bring bold advice and new ideas to its deliberations.

This has been a time of recovery with new energy and an improving appetite for fresh initiatives. All this could have only been achieved by a cohesive Board working well with the CEO and senior leadership team. I am very proud to lead such an organisation. All in all, a satisfying year in the wake of a severe shock to the system. A new normal, I trust, and also a better one, I hope. I thank all College staff and volunteers for their contributions.

TREASURER’S REPORT

Dr Christian Wriedt

in favourable unrealised gains, final net income was $3.4m. This was significantly higher than the previous year, which saw a $1.9m decline in investment valuations due to world-wide influences.

Medical Standards

The Financial Statements for the year ending 30 June 2023 along with the Auditor’s Report are presented in this document. A detailed version of the Financial Statements will be available on the College website www.ranzcr.com

FY 2023 was a favourable year with the College successfully delivering its core activities. The College’s financials also benefitted from the macro-economic environment with interest and investment incomes of $1.7m. This was higher than last year due to rising interest rates and appreciating global portfolio valuations. Operational revenues were exactly in line with budgeted expectations whilst expenses were materially lower than budget. The latter was driven by lower costs in the areas of travel ($900k), office expenses, and third-party expenses. In comparison to the previous year, expenses have increased due to the improvement in the general business environment.

Overall, revenues and expenses for the College increased by 19% and 15% respectively, compared to the previous year.

The College’s FY 2023 net surplus was $3.2m, and after an additional $0.2m

Membership revenue subscriptions grew 13% to $11.8m and remain at an average of 50% of total revenue income. The College also aligned to a new exam format mid-year. This saw a corresponding increase in exam fees and revenues to cover the continued large expense in supporting these exams. Other material revenue increases were from the successful annual ASM (Annual Scientific Meeting) in October 2022 and related sponsorship revenues. IMG (International Medical Graduates) and site accreditation revenues also increased from the previous year.

FY 2023 saw an environment of increasing CPI and supply-chain restrictions. This influenced some College expense areas such as recruitment, technology project work, and travel costs. As such the College prudently managed the growing need for staff to travel. Member engagements such as the ASM and committee meetings also saw increases in costs, as expected.

The College’s balance sheet position remains consistently strong. Cash and other assets cover the College’s liabilities more than two-fold (asset ratio: 2.2 times). This is a strong going-concern indicator and places the College’s finances in a firm position.

Policy and Advocacy

The College strongly engaged in representing its position at both Federal and State levels in advocacy and governance. This was across both Australia and New Zealand and included the areas of: program funding, workforce strategies, training, and health technology. The College also engaged in promoting a successful Targeting Cancer campaign.

During the year the College obtained government funding to support several projects such as Radiology Referrer Set, Stillbirth, iRefer - Modernisation of Diagnostic Imaging and MyHealth Records. Work was also done in developing a specialty training program in interventional radiology and interventional neuroradiology. In addition, the College also started developing a CPD Home environment for registering cross-professional development.

Program Funding

The new Regional and Rural Training Program (RRTP) pilot, to commence in 2024, became fully subscribed to and supports the development of an expanded regional and rural workforce and improving health outcomes in communities. The college has also been successful in filling all STP (Specialty Training Program) and IRTP (Integrated Training) positions and has been granted two extra STP and one more IRTP post for 2024 and 2025 for regional and rural training. The Department of Health and Aged Care has permitted the College to re-purpose some STP funding to encourage longer STP rotations in regional and rural areas.

Accreditation

The College’s Area of Need (AoN) program for IMGs was launched in 2023. 20 new sites were accredited in 2023 enabling IMGs to work in areas where radiologists are needed in regional and rural Australia. The first radiation oncology AoN was also accredited this year.

Admission to Fellowship

With increases in CPI, training and examination costs continue to be a major portion of overall expenses. However, during FY23 the Board resolved to reduce pricing for the initial admission to

fellowship fees. Also, the Board supported temporary relief in terms of offering payment plans in exceptional cases for those experiencing financial hardship.

Memberships

ASM 2022 saw a record-breaking attendance with a much wider engagement than expected. Several educational webinars were also run during the year. Post-COVID learning continues to be partly hybrid but with growing and beneficial face-to-face events.

Research committees have also developed an approved Research Action Plan to increase research rollout. A new volunteer recognition program was introduced. Improvements in membership management and responses was also implemented.

Financial Outlook FY2024

FY 2024 sees another volatile external year in terms of CPI, interest rates, pricing, and a potential recession. The College is partly resilient to these factors and is expected to deliver a net surplus of $1m for the year.

For the College, the year will see further developments in accreditation trainingsite programing, potential silicosis funding from the federal government, improved assessment and selection for training applications, and renewals of other government radiology funding programs. CPD Home will potentially result in some changes in peer-College memberships.

The College will also continue its planned investment in technology and membership delivery improvements with a capital budget of $0.4m. Some of these projects include improved payment gateways, CPD platforming and accreditation system (phase1).

A MESSAGE FROM THE CEO

Duane Findley

Zealand members play an outsized role in shaping the future of our profession and there are large RANZCR cohorts speaking at or attending key international conferences. RANZCR has also worked hard to reintroduce international training courses for our members and to reconnect us to our global partners. Our training and assessment programs for RANZCR trainees and IMGs continue to deliver outstanding graduates for Australia and New Zealand, with the FRANZCR post-nominal seen as a global gold standard. Our work on IR/INR recognition, digital health, CPD homes, reconnecting with SIGs, and other initiatives, has positioned RANZCR as trusted industry partners.

management, most notably around travel. The RANZCR Board made some difficult but necessary decisions to increase prices and this has ensured the longer term financial sustainability of the College.

As we look to the future, we remain committed to:

• Strengthening our educational offerings to meet the evolving needs of our members and the healthcare sector.

• Supporting research initiatives to drive innovation in our sector.

• Advocating for policies that prioritise the wellbeing of patients and the professional development and wellbeing of our members.

As we reflect on the past year, it is clear that the global healthcare landscape continues to evolve rapidly, presenting both opportunities and obstacles. In the face of these changes, RANZCR remains steadfast in its commitment to excellence in medical education, training and research, and to advancing the practices of radiology and radiation oncology across Australia, New Zealand and the broader region.

The return to a “new normal”, as the world adjusts to living with COVID, has seen a strong drive by our members to reconnect with each other, and to reconnect with colleagues from across the globe. Our delegate numbers at our Adelaide 2022 conference were the largest we’ve ever attracted, and early indications are that Brisbane 2023 will be larger again. In meeting with aligned international organisations, it is clear that RANZCR and its Australian and New

We’ve achieved a number of outstanding results from our policy and advocacy efforts and our expertise will be needed even more in the difficult years ahead.

Within the College, competition for staff has seen a higher-than-normal turnover during this financial year. This situation has stabilised and we have replaced departing staff with some excellent new talent.

The increasing regulatory burden on all specialist medical colleges and rapidly rising costs in a high inflation environment has placed extreme costs pressures on our College. As highlighted in a recent medical publication, a number of other colleges are operating at a loss; some have shed large numbers of staff and one has brought in an administrator to assist their restructure and recovery. In contrast, RANZCR has focused on realistic and sustainable cost

• Focusing on fulfilling the needs of our members.

• Enhancing collaboration with international medical institutions and organisations to further enrich our programs and knowledge exchange.

I want to express my deepest gratitude to the RANZCR Board, our dedicated staff, our members, and our partners for their unwavering support and commitment to the College. I also extend my thanks to our members for their trust and continued engagement. Your continuing contribution and dedication to RANZCR is the driving force behind our success.

As we embark on a new fiscal year, I am confident that our College will continue to excel, adapt and innovate. With your support, we will remain at the forefront of medical education and development, research support and advocacy.

THE YEAR AT A GLANCE

1,600+:

30:

KEY ACHIEVEMENTS

Advice to Governments

Here are some of the highlights actioned by the College’s Policy and Advocacy Unit:

• Provided a pre-budget submission to the Australian Government resulting in funding of breast markers on Medicare.

• Developed a NZ Election Priorities document and met with NZ political parties including the current Health Minister to discuss radiation oncology workforce shortages.

• The NZ Government has confirmed an additional 15 radiology and five radiation oncology training places and agreed to fund the radiation oncology fellowship we called for.

• Acted as a trusted advisor to the Australian Federal Government and the New Zealand Government on 11 submissions including feedback on the Health Technology Assessment Policy and Methods Review and the NZ Women’s Health Strategy.

• Our advocacy resulted in MRI licence deregulation to MMM 2-7 areas.

Specialist Training Program

During the period, five new Specialist Training Placements and Support (STPS) posts commenced. A total of 50 funded STPS posts were secured, of which 28 were private, with additional three clinical radiology posts bundled with metropolitan settings. The number of STPS posts located in Modified Monash (MM) category MM2 – MM7 has increased to 28 during the year.

A total of five funded Integrated Rural Training Pipeline posts were secured, which continued to provide funding and support for regional and rural-based trainees.

Under Training More Specialist Doctors in Tasmania (Tas Project), an additional 1.5 posts commenced at Royal Hobart Hospital, which marked the full allocation of funding secured for the period.

Policy and Advocacy in Action Report

In a new initiative, the College unveiled its first Policy and Advocacy in Action Report, which provides details on our advocacy activities to influence government. Going forward, the report will be published twice a year to better communicate what we are doing for members.

Clinical Radiology Examinations

In 2023 the Clinical Radiology Phase 2 Examinations have transitioned to new formats, following on from the implementation of Phase 1 new formats in 2022.

The formats incorporate new question structures, applying robust methodologies for standard setting, application of statistical analysis and psychometric tools to identify Pass scores and Cut scores, as well as examiner training to apply the new rubric marking process.

Over the past 12 months candidates sat both the Phase 1 and Phase 2 written examinations at home using a Proctoring Service. Both the Viva delivered in 2022 and the June 2023 OSCER were held in Melbourne with candidates in one venue and examiners in a different venue.

Feedback from both candidates and examiners has been very positive regarding the new OSCER format. The results for Sitting 1 in 2023 for all examinations are set out below.

Accreditation

RANZCR continues to review the Accreditation Standards for both faculties, with a desktop trial of the radiation oncology accreditation standards having already taken place. This year the College has completed a total of 72 accreditation site visits (CR: 42 sites, RO: 30 sites).

The total number of accreditation assessors: 92 (15% increase)

• Clinical Radiology: 43

• Radiation Oncology: 49

The total number of accredited training sites: 236

• Clinical Radiology: 181 (increase of 20)

• Radiation Oncology: 55

Targeting Cancer

On World Cancer Day 2023, cervical cancer survivor and Wadi Wadi, Wandi Wandian and Dharawal woman Ashlee Williams shared her story to the media, helping to raise awareness on the importance of access to brachytherapy as a cancer treatment.

Radiation Oncology Examinations

The Phase 1 Examination in 2023 changed to individual papers in the three Oncology Sciences with new question items with multiple choice questions being asked in conjunction with short answer questions and scheduled to be delivered twice a year.

The new examination format provided an opportunity for examiner training not only in question item writing but also the marking process on the new digital examination platform.

Phase 2 Examinations

The Phase 2 Series 1 Examination in 2023 saw, for the first time since the Series 2, 2019 examinations, all examiners at the same site to conduct the Viva examinations with the examinations being delivered in a digital online format and candidates sitting their Viva remotely.

Pass Rates: 23 candidates met all Phase 2 Examination requirements and will be eligible for Fellowship subject to completing all the other requirements of the training program or IMG assessment requirements.

The examinations for both Phase 1 and Phase 2 in 2023 were also delivered successfully and without incident for the first time on a digital examination platform.

Interventional Radiology and Interventional Neuroradiology

• RANZCR is committed to advancing interventional radiology and interventional neuroradiology as clinical radiology specialties, and has submitted initial applications to the Medical Board of Australia to recognise these as new fields of specialty practice under the Health Practitioner Regulation National Law.

• To complement this work, the College is currently developing two dedicated, contemporary training programs for interventional radiology and interventional neuroradiology that are based on advanced training learning principles. This will be supported by ‘Learning Domains’ that have been identified by those common to both interventional radiology and interventional neuroradiology as well as specific domains and will cover the clinical and procedural knowledge and skills required for interventional radiologists and interventional neuroradiologists.

CPD and Professional Practice

• The RANZCR ePortfolio is now is its second calendar year of use and member feedback has been used to make refinements to the CPD components to improve user experience and functionality.

• RANZCR CPD staff have continued to provide support and assistance to members who have questions regarding the new CPD requirements and the RANZCR ePortfolio. This support ranges from telephone and email as well as e-newsletters to attending the Annual Scientific Meetings in Australia and New

Zealand and presenting at hospital and practice meetings to help members familiarise themselves with the new CPD program and the ePortfolio.

• Significant progress has been made towards updating the CTCA training guidelines to ensure they are better aligned with the daily practice and standards of the specialty of radiology.

Standards and Quality

• Standards of Practice for Clinical Radiology v11.2 has undergone a significant review, with a new and contemporary format. The standards have been consulted on with College members and external stakeholders – this is expected to be published in 2024.

Evaluation

• An internal review of selected training program survey tools has been undertaken, which has resulted in the decision to decommission one trainee survey, contributing to reducing the survey burden on trainees. A new format for the Director of Training Survey report has been introduced, which will provide an additional level of insight to the feedback.

Stillbirth Investigation Project

RANZCR showcased a six-part Perinatal Postmortem Imaging Webinar Series delivered online from October 2022 – May 2023. This webinar series provides foundational education to clinicians around the current landscape of postmortem investigation of stillbirth in Australia, and new innovations in regard to medical imaging for postmortem investigations.

Digital Health

• Continuation of the development of the Radiology Referral Set including development manual and catalogue to track coverage of the RRS development.

• Pilot of GPs (general practitioners) using iRefer to demonstrate the potential benefits that imaging guidelines can bring to the Australian healthcare system as an evidence-based resource to support GPs in choosing the right test at the right time for best patient care.

• CDS (Clinical Decision Support) workshop series to investigate CDS as a driver of quality for radiology imaging requesting in general practice.

Research

The College launched its new Research Action Plan 2023-2025, which outlines the key initiatives we’ll use to reach our research goals, and supports our strategic priority of clinical excellence. As the organisation responsible for leading, training and sustaining professionals in clinical radiology and radiation oncology, RANZCR will grow the profile of, engage with and participate in research across the professions.

NEW FELLOWS

Australian Capital Territory

Ayesha Arora

Sean Barrett

Jeffrey Chen

Jeremy Szajer

New South Wales

Khalid Alsahli

Rahul Anand Kumar

Ayomikun Asonibare

Jayraj Bhatti

Ryan Braun

Michael Carey

Benson Cheung

Jia Lin Chua

Samuel Conyngham

Mihir Desai

Jessica Dortmans

Matthew Eniola

Rusiru Gunawardena

Grace Hennessy

Allister Howie

Hannah Ireland

Peter James

Simren Kaur

Matthew Knox

Ratna Koyyalamudi

Ngo Le

Sarah Leeson

Isaac Lui

Patrick Markey

Simon McQueen

Adil Naeem

Robert Ng

Lucas Nunes da Silva

Dhruvbhai Patel

Clinton Smith

Jarrah Spencer

Mitchell Sutton

Yan Hao Tan

Izak Van der Walt

Joseph Wehbe

Viola Whitaker

Suet Wan Wong

Juliana Yee

Jun-Liang Zang

New Zealand

David Anderson

Rahul Bera

Sina Daneshmandi

Andrew Griffiths

Sandra Kieser

Laura Mayhew

David John Midgley

Catherine Rule

Lotte Steffens

Soo Chin Teo

Selvaraj Vasanthan

April Xu-Holland

Zubayr Zaman

Overseas

Matthew Adams

Revadhi Chelvarajah

Peregrine Dalziel

Priyank Gupta

Cassandra Jeavons

Dipesh Jogi

Christopher Newman

Sheila Oh

Maya Patel

Sarah Robertson

Christine Tang

Owen Terreblanche

Leonard Tiong

Queensland

Sameh Saied Ali

Sarah Cameron

Beini Chen

Marianne Cossens

Jeyprada Deenadayaalu

James

Brook Gulhane

Sachintha Hapugoda

Mona Hiba

Hana Issa

Alborz Jahangiri

Peter Jenvey

Sharmin Korda

Nai Kid Lai

Sophia Ly

St John Newman

Patricia O’Gorman

Bharti Rathi

Tracy Sexton

Karan Singh

Alexandra Slater

Thomas Smith

Ross Smith

Benjamin Sparreboom

Corey Thompson

South Australia

Kimberly Brown

Michael Croft

John Freebody

Paul Mikhail

Mohamed Mohamed

Melissa Newton

Jenan Sing Ern Ngo

Makenze Roberts

Frank Saran

Tasmania

David Benjabutr

Victoria

Sebastian Belfrage-Maher

Matthew Brain

Edward Chan

Chris-Tin Cheng

Michelle Chua

Jan Fletcher

Edward Ganly

Angela Hoskins

Ning Kam

Nicholas Karsz

Kendrick Koo

Vinicius Labrea Resende

Lincoln Lim

Miles MacBain

David McArdle

Jeewaka Mohotti

Kane Nicholls

Michael Paks

Hirantha Peiris

Anish Raithatha

Scott Robson

Shohreh Sadrarhami

Lionel Sugathadasa

Sonal Udayasiri

Cristian Udovicich

Georgina Venn

Hayley Wong

Mary Xu

Jeremy Yesudas

Renee Yetton

Western Australia

Sweeka Alexander

Caris Chong

Matthew Clifford

Fionn Coughlan

Murray Di Loreto

Shashini Dissanayake

Jonathan Erickson

Andrea Carola Ertmer

Robert Henderson

Thilina Jayaratne

Gunarathge Sunimali

Jayaweera

Brendan Koo

Joel Kranz

BeomJun Lee

Aden McLaughlin

Frederick Ong

Rose Radic

Rajalakshmi Ramesh

Leeshana Reddy

Arjun Shivananda

SUPPORT FROM OUR MEMBERS AND SPONSORS

College Donors

We are grateful to the members and fellows who have donated to the annual appeals.

Abdul Rahim Mohd Tahir

Amanda Whitney Palmer

An-Chi Mu

Blake William Milton

Brunie Mary Danga-Christian

Chandrika Dilhani Ranasinghe

Arachchige

Conor Paul Murray

Darryl Shnier

Sponsors

We acknowledge the valuable support provided through the year by our supporters and sponsors.

3M Health Information Systems

AdvaHealth Solutions

AGFA HealthCare

alphaXRT

Althea Australia

Annalise.Ai

ARTRYA

AstraZeneca

Austin Health

Bard Australia Pty Ltd

Bayer Australia

Blackford

Brainlab Australia

Cancer Institute NSW

CancerCare

Canon Medical Systems

Capital Radiology

CDN - Central Data Networks

Cipla Australia

Comrad Medical Systems

David Boshell

David Byram

Dorothy Chilambe Lombe

Edward Chege Nganga

Elton Zheng

Garvin Bryce Williamsz

Geoffrey Samuel Peretz

Gregory Charles Wheeler

Hawraa Al-Naqshabandi

Jan Harm Labuscagne

Joseph Richter

Joseph Stephen Fasulakis

Kester Ozuem Maduadi

Kim-Son Nguyen

Krishna Bharat Boddupalli

Ky McGrillen

Linda Mary Ashley

Lizbeth Moira Kenny

Mandakini Siwach

Mark Christopher James

Craddock

Matthew Anuoluwapo Eniola

Melanie Cecilia Robert

Muhammad Fahad Shahzad

Shaukat

Neil Gavin Berlinski

Peter Richard Downey

Peter Robert English

Piyush Paramhans Siwach

Pradeep Sonwalkar

Sandeep Waman Joshi

Sandhya Madhu Menon

Sanjay Jeganathan

Saurav Gupta

Shashi Ranjan

Sinead Dominica Hanley

Solokara Mudiyanselage

Thusha Karunarathne

Stanley Rajapakse

Tulasi Ramanarasiah

Verity Ann Ahern

Vidisha Krishnachandra

Vaidya

EIZO Oceania

Elekta

Epix-X

Everlight Radiology

EverX

Foxo Technology

Fujifilm Australia

GCG Global Healthcare

Pty Ltd

GE HealthCare

Guerbet

Healthinc Pty Ltd

Hologic ANZ

Home Loan Solutions

Hospital Staff Solutions

I-MED Radiology Network

Integral Diagnostics

Intelerad Medical Systems

I-TeleRAD

Kestral

LG Electronics

Lumus Imaging

MD Solutions Australasia

MDA National

Medfin - NAB Health

Medical Financial Advisers

Medical Wealth Advisory

Medx Radiology

Micro X

MIGA

Mundipharma

Nuance Communications

Ireland Limited

Oxlade Financial Pty Ltd

Palette Life Sciences Australia

Pty Ltd

Philips

PracticeHub (part of Avant)

Prescript Recruitment

Professional Radiology

Outcomes

Qscan Group

Sectra

See-Mode

Siemens Healthineers

Soliton IT

Stratpharma

Telix Pharmaceuticals (ANZ)

Pty Ltd

TeraRecon

Varian

Vision RT

Volpara Health

Voyager Imaging

AUDITOR’S REPORT

Australian Charities and Not-for-profits Commission Act 2012

Australian Charities and Not-for-profits Commission Act 2012

Australian Charities and Not-for-profits Commission Act 2012

Australian Charities and Not-for-profits Commission Act 2012

Australian Charities and Not-for-profits Commission Regulation 2013

APES 110 Code of Ethics for Professional Accountants

Australian Charities and Not-for-profits Commission Act

Australian Charities and Not-for-profits Commission Act 2012

Australian Charities and Not-for-profits Commission Act 2012

FINANCIALS

The Royal Australian and New Zealand College of Radiologists

Statement of profit or loss and other comprehensive income

For the year ended 30 June 2023

The above statement of financial position should be read in conjunction with the accompanying notes

The

Royal Australian and New Zealand College of Radiologists

Statement of financial position

As at 30 June 2023

The above statement of financial position should be read in conjunction with the accompanying notes

The Royal Australian and New Zealand College of Radiologists Statement of changes in equity For the year ended 30 June 2023

The above statement of financial position should be read in conjunction with the accompanying notes

The Royal Australian and New Zealand College of Radiologists Statement of cash flows

For the year ended 30 June 2023

The above statement of financial position should be read in conjunction with the accompanying notes

COLLEGE GRANTS, AWARDS AND PRIZES IN THE YEAR 2022-2023

College Honours

Gold Medal

A/Prof Dinesh Varma

Roentgen Medal

A/Prof Brigid Hickey

Honorary Fellowship

Prof V Massaro

Clinical Radiology Educational Service Award

Dr P J Ziesing

Denise Lonergan Educational Service Award

Dr R K Mukherjee

Life Membership

Dr Michael Baker

Dr Anita Bourke

Dr Lynne Brothers

Dr Charles Lott

Dr John Matthews

A/Prof Ross O’Neil

Clin A/Prof Elizabeth Wylie

Sally Crossing Award for Consumer Advocacy

Ms J Gibson

Research Awards and Grants

Faculty of Radiation

Oncology Bourne and Langlands Prize

Dr A K Lawless

Clinical Radiology Early Career Researchers Prize

Dr H K M Leonard

Radiation Oncology Research Grants

Dr Natalie Collier

Dr Lachlan Mcdowell

Dr Gishan Ratnayake

Clinical Radiology Research Grants

Dr Hussein Abbouchie

Dr Hugh McHugh

Dr William Ormiston

Dr Minh Son To

Wiley Best Exhibit Award

Radiation Oncology

A/Prof Wee Loon Ong

Wiley Best Exhibit Award

Clinical Radiology

Dr Sarah Constantine

NZ Radiology Education Trust Poster Prize

Dr Harry Alexander

Educational Fellowships

Thomas Baker Fellowship

Dr S M Stott

Bill Hare Fellowship

Adj/Assoc Prof H M L Frazer

Rouse Travelling Fellowship

Dr M L Yap

International Development Fund

Dr M L Yap

Exam Prizes

CE Eddy Prize Radiation Oncology

Dr Ann-Marie Nguyen

Dr Wei Shyan Soon

ASM Awards and Prizes

Radiation Oncology Varian Prize

Dr A Knight

Dr S Samaranay

DECEASED MEMBERS

It is with regret that we record the deaths of the following members during the year under review:

Dr Ronald Andrew, SA

Dr John Andrews, VIC

Dr Trevor ApSimon, WA

A/Prof Kevin Bell, VIC

Dr Ruwanpura De Silva, NSW

Dr Lan-Anh Do, SA

Dr Bryan Ebert, SA

Dr Barry Ganguly, SA

Dr Brigid Hickey, QLD

Dr Robert Mackay, QLD

Dr Donald McDonald, NSW

Wiley Best Exhibit Award

Radiation Oncology

A/Prof W L Ong

Elekta Award

A/Prof E Koh

ASM Prize Recipients

Clinical Radiology Branch of Origin

Dr Jemma Ford

Dr Stewart Leason

I-MED Best Emergency Radiology Scientific Exhibit

Dr S Srinivasan

Chris Atkinson Award

– Best Radiation

Oncology Scientific Paper

Presentation

A/Prof E Koh

Branch Awards

Obex William A Cook Award (NZ)

Dr Hugh McHugh

FRONNZ Prize (NZ)

Dr Bomi Kim

Dr Jann Medlicott, NZ

A/Prof Graeme Morgan, NSW

Dr Katrina Newbigin, QLD

Dr John Roysmith, VIC

Dr William Turnbull, NSW

Dr T Shailer Weston OBE VRD, NZ

Dr Raynor Williams, WA

Level 9, 51 Druitt Street, Sydney NSW 2000, Australia. ABN 37 000 029 863

T +61 2 9268 9777

E ranzcr@ranzcr.edu.au

Floor 6, 142 Lambton Quay, Wellington, New Zealand

T +64 4 472 6470

E nzbranch@ranzcr.org.nz

www.ranzcr.com

Copyright for this publication rests with The Royal Australian and New Zealand College of Radiologists®